Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

33 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Clinic-based ART Diagnostic Evaluation

NCT01791556

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Kenya Medical Research Institute/ Walter Reed Project HIV Program Kericho, Kenya

View Trial Details

Completed

Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe

NCT05307991

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +27 more
Locations: Bwaila STI clinic Lilongwe, Malawi

View Trial Details

Completed

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

NCT03301051

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Site 222 Mobile, Alabama, United States

Site 210 Anaheim, California, United States

Site 223 Milford, Connecticut, United States

Site 217 Coral Gables, Florida, United States

View all 73 locations

View Trial Details

Completed

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

NCT03321968

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: Site 205 Halifax, Nova Scotia, Canada

Site 208 Burlington, Ontario, Canada

Site 207 Guelph, Ontario, Canada

Site 202 Toronto, Ontario, Canada

View Trial Details

Completed

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

NCT03739112

Conditions: Infections, RNA Virus Infections, Respiratory Tract Diseases, +2 more
Locations: (Site 225) Coastal Clinical Research Mobile, Alabama, United States

(Site 201) Clinical Research Consortium Tempe, Arizona, United States

(Site 213) Advanced Clinical Research Banning, California, United States

(Site 246) Paradigm Clinical Research / Pharmaseek Redding, California, United States

View all 104 locations

View Trial Details

Completed

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

NCT04644484

Conditions: Communicable Disease, Communicable Diseases, Disease Attributes, +8 more
Locations: Yunnan Province Center for Disease Control and Prevention (CDC) Kunming, China

View Trial Details

Completed

ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

NCT04367740

Conditions: Asymptomatic Condition, Asymptomatic Diseases, COVID-19, +18 more
Locations: Center for Environmental Medicine, Asthma and Lung Biology Chapel Hill, North Carolina, United States

View Trial Details

Completed

EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19

NCT04822818

Conditions: Corona Virus Infection, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations: Hôpital TENON Paris, France

View Trial Details

Completed

COVID-19 and SARS-CoV-2 Detection in Saliva

NCT04517682

Conditions: Infections, RNA Virus Infections, Virus Diseases
Locations: Ambry Genetics Aliso Viejo, California, United States

View Trial Details

Completed

DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients

NCT03642977

Conditions: Blood Virome, DNA Virus Infections, Hematopietic Stem Cell Transplantation, +3 more
Locations: University Hospitals of Geneva Geneva, Switzerland

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions